(R)-5-(((S)-1-(((3S,6R,9S,12R,15S,18R,21S)-9-((1H-imidazol-4-yl) methyl)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-6-(carboxymethyl)-15-isopropyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13, 16,19-heptaazacyclopentacosan-21-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-4-((S)-2-((R)-2-((1S,2S)-1-amino-2-methylbutyl)-4,5-dihydrothiazole-4-carboxamido)-4-methylpentanamido)-5-oxopentanoic acid, 2,2,2-trifluoroacetic acid (1:3)
Bacitracin EP Impurity C Tritrifluoroacetate is a fully characterized chemical compound used as a reference standard of API Bacitracin. The standard offered is compliant with regulatory guidelines. Bacitracin EP Impurity C Tritrifluoroacetate is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Bacitracin EP Impurity E (Bacitracin F) (Mixture of Diastereomers)
M.F.
M.W. 1419.67
CAT# AR-B05880
CAS# NA
Bacitracin EP Impurity H Ditrifluoroacetate (Mixture of Diastereomers)
M.F.
M.W. 1405.64 2*114.02
CAT# AR-B05875
CAS# NA
